Updated: Jan 5, 2009
Little league elbow (LLE) syndrome is a valgus overload or overstress injury to the medial elbow that occurs as a result of repetitive throwing motions. Over the past several decades, the number of organized sports for children has grown significantly, with millions of children participating in organized athletics each year. This increase in participation has been paralleled by an increase in sports-related injuries in the pediatric population.1,2,3,4,5,6,7,8,9,10,11
Increased single-sport participation with year-round training, higher intensities at young ages, and longer competitive seasons are contributing factors to the increased injury rates seen in pediatric athletes. Conditioning and training errors also contribute significantly to the risk and frequency of injury. Although briefly discussed below, injuries to the lateral, posterior, and anterior elbow are separate entities and should not be confused with the medial injuries referred to as little league elbow syndrome.
During the throwing motion, valgus stress is placed on the elbow. This valgus stress results in tension on the medial structures (ie, medial epicondyle, medial epicondylar apophysis, medial collateral ligament complex) and compression of the lateral structures (ie, radial head, capitellum). Repeated stress results in overuse injury when tissue breakdown exceeds tissue repair. Recurrent microtrauma of the elbow joint can lead to little league elbow, a syndrome that encompasses (1) delayed or accelerated growth of the medial epicondyle (medial epicondylar apophysitis), (2) traction apophysitis (medial epicondylar fragmentation), and (3) medial epicondylitis.1,8,12,13,14,15
Medial epicondylar apophysitis and stress fractures through the medial epicondylar epiphyses caused by repetitive valgus stress generally manifest with progressive medial pain, decreased throwing effectiveness, and decreased throwing distance.
Other causes of medial elbow pain include avulsion fractures of the medial epicondyle and ulnar collateral ligament (UCL) sprains or tears. Although a fracture is usually an acute traumatic event, a preceding history of medial elbow pain is common and is thought to be a risk factor for progression to acute fracture. Therefore, any thrower who is experiencing medial elbow pain should refrain from pitching until he or she has had a thorough evaluation.1,3,5,8,16
A medial epicondyle fracture manifests as point tenderness and swelling over the medial epicondyle, often with an elbow flexion contracture greater than 15°. Repetitive medial stress can also cause attenuation and microstretching of the UCL complex, causing mild instability over time.1
UCL injuries can manifest as acute ligament tears following a single valgus stress or as overuse sprains following repetitive valgus overloads. The clinical presentation is similar to little league elbow; however, the typical age range of the athlete is the older teenager who is skeletally mature. Suspected UCL injuries should be referred for further evaluation by a sports medicine specialist. Athletes with UCL injuries should not be allowed to pitch until they have been evaluated.
Although uncommon in children, neurologic injuries such as C8-T1 radiculopathy and ulnar neuritis can manifest as medial elbow pain and should be included in the differential diagnosis (see Differentials and Other Problems to Be Considered).
Lateral compression of the elbow most frequently results in injuries to the capitellum and radial head. Osteochondrosis of the capitellum (known as Panner disease) generally occurs in children aged 7-12 years and manifests as dull, achy, activity-related lateral elbow pain. Swelling, clicking, and decreased range of motion are uncommon associated symptoms. Panner disease tends to be a benign self-limited condition that does well over time and is treated with complete rest from inciting activities such as throwing and weight bearing on the elbow. Osteochondral injuries can also be observed in the radial head.
Osteochondritis dissecans (OCD) of the capitellum occurs in adolescents aged 13-17 years. This is a localized injury to subchondral bone that results from repetitive lateral compression of the elbow during overhead motions. These patients report a general dull elbow pain that worsens with activity, often have a flexion contracture of 15° or greater, and may have mechanical symptoms of clicking or popping. Loose body formation, residual capitellum deformity, and elbow degenerative joint disease are potential sequelae. Different treatment options are used based on the age and skeletal maturity of the patient and the type of lesion present.
Osteochondritis dissecans lesions can be separated into type I, which has no displacement and no articular cartilage fracture; type II, which has evidence of articular cartilage fracture or partial displacement; and type III, which is completely displaced with loose bodies in the joint.
Posterior elbow injuries also occur as a result of throwing. During the follow-through stage of throwing, extension overload and valgus stress can result in injury of the olecranon. These athletes present with posterior elbow pain, clicking, and possible loss of elbow extension. Loose bodies and olecranon nonunion can occur in younger athletes. Older athletes may experience olecranon fractures or secondary osteophyte formation. These injuries are sometimes treated surgically.1,3,4,5,6,7,9,10,11,17
For excellent patient education resources, visit eMedicine's Hand, Wrist, Elbow, and Shoulder Center and Sports Injury Center. Also, see eMedicine's patient education article Repetitive Motion Injuries.
Related eMedicine topics:
Floating Elbow
Tendonitis
Ulnar Nerve Entrapment
Annually, an estimated 4.8 million children aged 5-14 years participate in baseball and softball. The incidence of all baseball-related overuse injuries is 2-8% per year. The incidence of overuse injuries in the 9- to 12-year-old range for baseball is 20-40%, and in the adolescent age group is 30-50%. The true incidence of sports-related injuries is unknown because a large number of athletes never seek medical care. Early recognition of little league elbow syndrome is important, because it leads to better outcomes and decreases the risk of persistent functional disabilities in the athletes.
No data are available for the annual incidence of little league elbow syndrome in the international community.
Evaluation of the young adolescent elbow presents some anatomic challenges to the healthcare provider in that the elbow consists of numerous ossification centers and cartilaginous physes. Becoming familiar with the chronologic order of appearance and ossification of these growth centers is important. Consider the mnemonic CRITOE (ie, capitellum, radius, internal epicondyle, trochlea, olecranon, external epicondyle).
Each of the ossification centers appears at a relatively predictable time starting around age 1-2 years, with 2-year intervals between the next center's appearance. Closure of each of the apophyses occurs from age 14 to 16 years, with the medial epicondyle specifically closing at approximately age 15 years. The elbow likely reaches full skeletal maturity by the late teen years, at which time injuries to the UCL are far more common. Until then, the young thrower is at risk for little league elbow syndrome.1,4,12,16,18
The static stabilizers around the elbow include the bony articulations, the joint capsule, and the various ligament bundles. The medial (ulnar) collateral ligamentous complex consists of the anterior oblique bundle, posterior oblique bundle, and transverse ligament. These structures are the primary medial support of the elbow during valgus stress. The lateral (radial) ligamentous complex, composed of the lateral collateral, lateral ulnar collateral, and accessory lateral collateral ligaments, provides support during varus stress.
The dynamic stabilizers primarily include the muscles that cross the elbow joint, such as the triceps, biceps, and brachioradialis. The flexor-pronator group stabilizes against valgus stress, and the extensor-supinator group stabilizes against varus stress.
Elbow biomechanics include flexion/extension range of motion and pronation/supination. Slight hyperextension 5-15° through flexion of approximately 150° is within normal limits. Baseball pitchers with years of throwing experience often have relative 5-10° flexion contractures on their dominant side; however, in the young thrower, a flexion contracture can be a sign of injury. Pronation of 75° and supination of 85° is normal. Varus-valgus laxity of 3-4° is normal.
One should be familiar with the stages of throwing to understand the complexities of the biomechanical forces that contribute to the young thrower's risk of injury, such as in little league elbow syndrome. The pitching or throwing motion can be divided into 6 stages. Medial elbow injuries are the most common type seen in throwers and occur most commonly in the cocking and acceleration phases of throwing, owing to the presence of maximum valgus extension or distraction forces.1,12,13,14,15
Elbow and Forearm Overuse Injuries
Elbow Dislocation
Humeral Capitellum Osteochondritis
Dissecans
Lateral Epicondylitis
Medial Epicondylitis
Ulnar Collateral Ligament Injury
Cervical strain with radiculitis
Child abuse
Cubital tunnel syndrome or ulnar nerve subluxation at the cubital tunnel
Posterior interosseous nerve or radial nerve entrapment syndrome
Stress fracture
Septic arthritis
Ulnar neuritis
The most important part of treatment for little league elbow syndrome is physical therapy. Rehabilitation in general follows a logical and sequential progression to quickly and safely return the athlete to a preinjury level of function.
The initial treatment phase involves limiting immobilization as much as possible, with initiation of range-of-motion exercises and joint mobilizations as necessary to prevent joint contractures. For athletes with hypermobility, joint stabilization exercises may be beneficial. Treatment of pain and inflammation with icing regularly, 20 minutes 1-2 times per day is important. Anti-inflammatory medications may used as needed to treat pain and may also help treat inflammation when present.
Appropriate upper extremity stretching and strengthening exercises can be initiated as tolerated with the use of dumbbells or light resistance bands. Elbow braces are of limited benefit but may be used for comfort or to promote active full range of motion. A core strengthening program should also be initiated immediately. Athletes should be able to start core exercises before the ability to perform specific elbow strengthening exercises.
Occupational therapy for little league elbow syndrome can include efficient, practical ways to perform activities of daily living. Usually occupational therapy is of limited benefit to athletes with little league elbow syndrome, and the incorporation of upper extremity therapy with core strengthening and a biomechanical throwing analysis is of maximal benefit to the athlete. This integrated treatment approach is usually coordinated through physical therapy.
Most complications from little league elbow syndrome arise from a thrower attempting to return to pitching too soon before rehabilitation is complete, or they result from a pitcher who continues to play while symptomatic. The presence of pain while performing competitive pitching is highly correlated with an increased risk of medial epicondylar avulsion fracture and the subsequent need for surgical stabilization. Athletes should be counseled to stop or avoid pitching at any time when elbow pain is present, and these individuals should seek an evaluation by a healthcare professional before returning to pitching.
Medial epicondylar fractures may require either closed reduction and casting or surgical reattachment with fixation if displacement, elbow instability, or failure of conservative treatment occurs.1,3,17
Type II osteochondrotic lesions are treated surgically if the loose body interferes with motion or causes mechanical symptomatology (eg, locking, buckling). Techniques of surgical treatment include removing loose bodies, drilling to stimulate active repair, bone grafting when architectural support is needed, or reattachment with absorbable or nonabsorbable Kirschner wires (K-wires). Type III lesions are usually treated with loose body removal, with or without drilling, curettage, or reattachment with K-wires.
When loose bodies or osteophytes are present in patients with olecranon injuries, surgical removal may be indicated in those who are symptomatic. Bone grafting may also be used in cases of olecranon nonunion when rest and immobilization have failed.
It is important to note that all throwers who have had surgical treatment for elbow pain require some form of progressive rehabilitation following the principles outlined above, including a thorough biomechanical pitching analysis. Pitchers should be counseled that many do not return to the previous level of throwing following surgical treatment of elbow injuries; however, outcomes vary based on the individual circumstances.
Consultation with a rheumatologist is sometimes indicated in children who have chronic elbow pain and swelling that cannot be explained by an appropriate sports-related mechanism of injury. Infectious disease specialists can be helpful in the rare cases of joint or bursal infections, which do occur at the elbow.
During the recovery phase of treatment, the athlete with little league elbow syndrome should begin a progressive throwing program. Usually, this phase occurs at approximately week 4-8 of treatment. The criteria to progress to the more advanced recovery phases include full, nonpainful range of motion, no tenderness to palpation, normal symmetric upper extremity strength, good core stabilization, and good balance.
The return to throwing begins with a careful assessment of pitching mechanics by a rehabilitation specialist, such as an experienced physical therapist, certified athletic trainer, or a pitching coach. Video analysis can provide a more detailed and sophisticated analysis of throwing. Long tosses and noncompetitive pitches should emphasis neuromuscular core stability and proper arm positioning through each of the 6 phases of throwing, from windup to follow-through (see Sport-Specific Biomechanics).
Most complications arise out of a thrower attempting to return to pitching too soon before rehabilitation for little league elbow syndrome is complete or result from a pitcher who continues to play while symptomatic. The presence of pain while performing competitive pitching is highly correlated with an increased risk of medial epicondylar avulsion fracture and the subsequent need for surgical stabilization. Athletes should be counseled to stop or avoid pitching at any time when elbow pain is present, and they should seek an evaluation by a healthcare professional before returning to pitching.
Surgical treatment is usually not indicated in the recovery phase, unless the patient’s recovery is halted by either new or previously unrecognized symptomatology, such as loose bodies or osteophytes. Such symptoms can be treated as described previously (see Acute Phase Surgical Intervention). Indeed, a lack of further progression in the recovery phase sometimes indicates a previously unrecognized problem with regard to the child’s elbow. This situation may require further diagnostic studies, which may include repeat plain radiographs, MRIs in younger children, and/or bone scans or CT scans.
Joint injections and manipulations are not appropriate forms of treatment in patients with little league elbow syndrome.
The maintenance phase of recovery from little league elbow syndrome should include careful observation for any recurrence of symptoms, including pain, loss of strength, loss of endurance, loss of power, or neuromuscular fatigue. The patient must be vigilant to maintain proper throwing biomechanics at all times for noncompetitive and competitive pitching. Careful attention should be paid to pitch counts and types, as outlined below, based on the age, ability, and playing level of the athlete. Failure to follow the appropriate guidelines as outlined or any attempt to pitch through relapses in symptoms can result in an increased risk of reinjury.
A gradual recurrence of symptoms of little league elbow syndrome indicates a treatment failure or an improper diagnosis. Athletes with recurrent symptoms should be evaluated by a sports medicine specialist and should refrain from all competitive throwing. Even with a reasonable long-term maintenance program, complications such as posttraumatic arthritis, permanent flexion contractures, and growth or angular deformities may occur.
Consultation with a sports orthopedic surgeon or sports medicine specialist may be necessary if the individual with little league elbow syndrome cannot be easily kept in the maintenance phase.
The goals of pharmacotherapy are to reduce morbidity and prevent complications in little league elbow syndrome. The primary effectiveness of nonsteroidal anti-inflammatory drugs (NSAIDs) is in the treatment of pain. Some cases of little league elbow syndrome have an inflammatory component that responds to the anti-inflammatory properties of NSAIDs.
NSAIDs have analgesic, anti-inflammatory, and antipyretic activities. The mechanism of action of these agents is not known, but they may inhibit cyclooxygenase (COX) activity and prostaglandin synthesis. Other mechanisms may also exist, such as inhibition of leukotriene synthesis, lysosomal enzyme release, lipoxygenase activity, neutrophil aggregation, and various cell membrane functions.
DOC for patients with mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.
400 mg PO q4-6h, 600 mg q6h, or 800 mg q8h while symptoms persist; not to exceed 3.2 g/d
20-70 mg/kg/d PO divided tid/qid; start at lower end of the dosing range and titrate; not to exceed 2.4 g/d
Coadministration with aspirin increases the risk of inducing serious NSAID-related adverse effects; probenecid may increase the concentrations and, possibly, the toxicity of NSAIDs; may decrease the effect of hydralazine, captopril, and beta-blockers; may decrease the diuretic effects of furosemide and thiazides; may increase PT duration when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase the risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
Documented hypersensitivity; peptic ulcer disease, recent GI bleeding or perforation, renal insufficiency, or high risk of bleeding
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Caution in the presence of congestive heart failure, hypertension, and decreased renal and hepatic function; caution in patients with coagulation abnormalities or during anticoagulant therapy
For the relief of mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing the activity of COX, which is responsible for prostaglandin synthesis.
250-500 mg PO bid; may increase to 1.5 g/d for limited periods
2.5 mg/kg/dose PO; not to exceed 10 mg/kg/d
Coadministration with aspirin increases the risk of inducing serious NSAID-related adverse effects; probenecid may increase the concentrations and, possibly, the toxicity of NSAIDs; may decrease the effect of hydralazine, captopril, and beta-blockers; may decrease the diuretic effects of furosemide and thiazides; may increase PT duration when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase the risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
Documented hypersensitivity; peptic ulcer disease; recent GI bleeding or perforation; renal insufficiency
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Acute renal insufficiency, interstitial nephritis, hyperkalemia, hyponatremia, and renal papillary necrosis may occur; patients with preexisting renal disease or compromised renal perfusion risk acute renal failure; leukopenia occurs rarely, is transient, and usually returns to normal during therapy; persistent leukopenia, granulocytopenia, or thrombocytopenia warrants further evaluation and may require discontinuation of the drug.
For the relief of mild to moderate pain and inflammation. Small dosages are initially indicated in small and elderly patients and in those with renal or liver disease.
Doses >75 mg do not increase the therapeutic effects. Administer high doses with caution, and closely observe the patient for response.
25-50 mg PO q6-8h prn; not to exceed 300 mg/d
<12 years: 0.1-1 mg/kg PO q6-8h
>12 years: Administer as in adults.
Coadministration with aspirin increases the risk of inducing serious NSAID-related adverse effects; probenecid may increase the concentrations and, possibly, the toxicity of NSAIDs; may decrease the effect of hydralazine, captopril, and beta-blockers; may decrease the diuretic effects of furosemide and thiazides; may increase PT duration when taking anticoagulants (instruct patients to watch for signs of bleeding); may increase the risk of methotrexate toxicity; phenytoin levels may be increased when administered concurrently
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Caution in patients with congestive heart failure, hypertension, and decreased renal and hepatic function; caution in the presence of coagulation abnormalities or during anticoagulant therapy
Return to throwing activities in individuals with little league elbow syndrome should be carefully monitored by the patient and his or her family in conjunction with an educated trainer, the coach, and a pediatric sports medicine or orthopedic specialist. The return to competitive pitching should begin when an athlete has fully completed his or her rehabilitation program. As the athlete returns to competition, careful attention to pitch types, pitch counts, a proper rotation schedule, and maintenance of core strength and flexibility is necessary.21
Maximum Pitch Counts — Game Competition | |||||
| Age, y | Pitch Approved to Throw | Pitches per Game | Pitches per Week | Pitches per Season | Pitches per Year |
| 9–10 | Fastball | 50 | 75 | 1000 | 2000 |
| 11-12 | Change-up | 75 | 100 | 1000 | 3000 |
| 13-14 | Curveball | 75 | 125 | 1000 | 3000 |
| 15-16 | Slider, forkball, splitter, knuckleball | 90 | - | - | |
| 17-18 | Screwball | 105 | - | - | |
Even with a reasonable long-term maintenance program, complications such as posttraumatic arthritis, permanent flexion contractures, and growth or angular deformities may occur following little league elbow syndrome.
Prevention can be accomplished by educating parents, players, and coaches about the symptoms and sequelae of little league elbow syndrome. Emphasis should be placed on proper throwing techniques during practices and games. Pitch counts, pitch types, and a proper rotation schedule should be followed. The number of competitive pitches thrown in practice and the number of innings per week, per season, and per year should be monitored. The prescreening physical examination affords an excellent opportunity for the physician to provide this information.
Proper warm-up time and proper strength and flexibility exercises should be maintained during the off-season or initiated at least 6 weeks before the first practice. Pitching should be limited to 9 months per year maximum, and an off-season interval throwing program is important. Proper biomechanics should be emphasized at all times. Athletes should be encouraged to seek medical care when symptoms of throwing-related elbow pain develop.
Prognosis for recovery from little league elbow syndrome is guarded and depends on the specific pathologic process. In general, disorders that affect the articular surfaces of the elbow, such as the capitellum and radial head, as well as those that affect the normal growth and development of the elbow have the worst long-term prognosis. Over the short term, most cases of little league elbow syndrome resolve with rest and conservative management. Osteoarthritis is a potential long-term complication. Functional disability and permanent deformity can result from proper or improper management.
Little league elbow syndrome, as well as other sports-related injuries, can be discussed with parents and players during the preparticipation physical examination. This is an excellent opportunity for physicians to educate their patients about causes, symptoms, and prevention of sports injuries.21
Bradley JP. Upper extremity: elbow injuries in children and adolescents. In: Stanitski CL, DeLee JC, Drez D Jr, eds. Pediatric and Adolescent Sports Medicine. Vol 3. Baltimore, Md: WB Saunders Co; 1994:242-61.
Benjamin HJ, Briner WW Jr. Little league elbow. Clin J Sport Med. Jan 2005;15(1):37-40. [Medline].
Congeni J. Treating and preventing little league elbow. Phys Sportsmed. 1994;22(3):54-64.
Emery HM. Considerations in child and adolescent athletes. Rheum Dis Clin North Am. Aug 1996;22(3):499-513. [Medline].
Micheli LJ. Overuse injuries in children's sports: the growth factor. Orthop Clin North Am. Apr 1983;14(2):337-60. [Medline].
Patel DR, Nelson TL. Sports injuries in adolescents. Med Clin North Am. Jul 2000;84(4):983-1007, viii. [Medline].
Rudzki JR, Paletta GA Jr. Juvenile and adolescent elbow injuries in sports. Clin Sports Med. Oct 2004;23(4):581-608, ix. [Medline].
Stanitski CL. Combating overuse injuries: a focus on children and adolescents. Phys Sportsmed. 1993;21(1):87-106.
Stanitski CL. Pediatric and adolescent sports injuries. Clin Sports Med. Oct 1997;16(4):613-33. [Medline].
American Academy of Pediatrics. Risk of injury from baseball and softball in children. Pediatrics. Apr 2001;107(4):782-4. [Medline]. [Full Text].
USA Baseball Medical & Safety Advisory Committee. Youth baseball pitching injuries. November 2008. USA Baseball.com. Available at http://mlb.mlb.com/usa_baseball/article.jsp?story=medsafety11. Accessed January 5, 2009.
Alcid JG, Ahmad CS, Lee TQ. Elbow anatomy and structural biomechanics. Clin Sports Med. Oct 2004;23(4):503-17, vii. [Medline].
Ben Kibler W, Sciascia A. Kinetic chain contributions to elbow function and dysfunction in sports. Clin Sports Med. Oct 2004;23(4):545-52, viii. [Medline].
Hutchinson MR, Wynn S. Biomechanics and development of the elbow in the young throwing athlete. Clin Sports Med. Oct 2004;23(4):531-44, viii. [Medline].
Loftice J, Fleisig GS, Zheng N, Andrews JR. Biomechanics of the elbow in sports. Clin Sports Med. Oct 2004;23(4):519-30, vii-viii. [Medline].
Behr CT, Altchek DW. The elbow. Clin Sports Med. Oct 1997;16(4):681-704. [Medline].
Maloney MD, Mohr KJ, el Attrache NS. Elbow injuries in the throwing athlete. Difficult diagnoses and surgical complications. Clin Sports Med. Oct 1999;18(4):795-809. [Medline].
Cain EL Jr, Dugas JR. History and examination of the thrower's elbow. Clin Sports Med. Oct 2004;23(4):553-66, viii. [Medline].
Colman WW, Strauch RJ. Physical examination of the elbow. Orthop Clin North Am. Jan 1999;30(1):15-20. [Medline].
Fritz RC, Breidahl WH. Radiographic and special studies: recent advances in imaging of the elbow. Clin Sports Med. Oct 2004;23(4):567-80, ix. [Medline].
Ronai J. Eight essentials of post-pitching recovery. USA Baseball.com. Available at http://mlb.mlb.com/usa_baseball/article.jsp?story=medsafety2. Accessed July 17, 2008.
little league elbow syndrome, little league elbow, medial epicondylitis, valgus elbow extension overload syndrome, medial elbow apophysitis, ulnar collateral ligament injuries, lateral elbow compression injuries, overuse elbow injuries, Panner’s disease, Panner disease, LLE syndrome, LLE, elbow injury, baseball injury, pitcher’s elbow, pitching injury
Holly J Benjamin, MD, FACSM, FAAP, Assistant Professor of Clinical Pediatrics and Surgery, Section of Orthopedic Surgery and Rehabilitation Medicine, The University of Chicago and The University of Chicago Physicians Group; Appointed Director of Primary Care Sports Medicine, The University of Chicago
Holly J Benjamin, MD, FACSM, FAAP is a member of the following medical societies: American Academy of Pediatrics, American College of Sports Medicine, and American Medical Society for Sports Medicine
Disclosure: Nothing to disclose.
Igor Boyarsky, DO, Director of Triage, Assistant Professor, Department of Emergency Medicine, King-Drew Medical Center, University of California at Los Angeles
Igor Boyarsky, DO is a member of the following medical societies: American Medical Association, American Medical Student Association/Foundation, American Osteopathic Association, American Society of Addiction Medicine, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Christian Rank, MD, Staff Physician, Department of Emergency Medicine, Martin Luther King/Charles R Drew Medical Center
Christian Rank, MD is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.
Eleby R Washington III, MD, FACS, Associate Professor, Department of Surgery, Division of Orthopedics, Charles R Drew University of Medicine and Science
Eleby R Washington III, MD, FACS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American College of Surgeons, American Medical Association, International College of Surgeons, and National Medical Association
Disclosure: Nothing to disclose.
Andrew D Perron, MD, Residency Director, Department of Emergency Medicine, Maine Medical Center
Andrew D Perron, MD is a member of the following medical societies: American College of Emergency Physicians, American College of Sports Medicine, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.
Jon B Whitehurst, MD, Clinical Instructor of Surgery, University of Illinois College of Medicine; Partner and Executive Board Member, Rockford Orthopedic Associates; Orthopedic Chairman, Rockford Memorial Hospital
Jon B Whitehurst, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, and Arthroscopy Association of North America
Disclosure: Nothing to disclose.
Sherwin SW Ho, MD, Associate Professor, Department of Surgery, Section of Orthopedic Surgery and Rehabilitation Medicine, University of Chicago
Sherwin SW Ho, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, and Arthroscopy Association of North America
Disclosure: Nothing to disclose.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)